Sinuva™ (mometasone furoate) – New drug approval
December 11, 2017 – Intersect ENT announced the FDA approval of Sinuva (mometasone furoate) sinus implant, for the treatment of nasal polyps in patients ≥ 18 years of age who have had ethmoid sinus surgery.
Download PDF
